Evaluating a new device for managing take-home methadone for opioid use disorder patients.
Official title: COPA: A clinical program to evaluate benefits of a hand-held, automated, personalized oral liquid dispensing system for take-home methadone medication management for patients with opioid use disorder.
Funded at Berkshire Biomedical Corporation · NIH-11168127 · Data updated 2026-11-12
This study is testing a handy device that gives personalized doses of methadone to help people with opioid use disorder manage their medication at home, making it easier for them to stick to their treatment and improve their quality of life.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Berkshire Biomedical Corporation NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project start | June 1, 2025 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $326,410 |
| NIH project number | 1R44DA061908-01A1 |
| Project ID | NIH-11168127 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with opioid use disorder who are currently receiving or are eligible for methadone treatment.
✕Less likely to help
Patients who are not diagnosed with opioid use disorder or those who are not eligible for methadone treatment may not benefit from this research.
What this research studies
This research investigates a hand-held, automated system designed to dispense personalized doses of methadone for patients with opioid use disorder (OUD). The goal is to improve medication management by allowing patients to take their medication home, thereby reducing the need for daily clinic visits. The study will assess the acceptability and feasibility of this device, focusing on how it can enhance treatment adherence and overall patient quality of life. By using a mixed methods approach, the research will gather both quantitative and qualitative data from participants to understand their experiences and outcomes with the device.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence and quality of life for patients with opioid use disorder.
How similar studies have gone: Previous research has shown that flexible take-home dosing can improve treatment retention and patient outcomes, suggesting that this approach may be effective.
Where this research is happening
-
Berkshire Biomedical Corporation
Dallas, United States Active
Researchers
- Principal investigator: Timberlake, John — Berkshire Biomedical Corporation
- Study coordinator: Timberlake, John
Related research
Other NIH-funded projects on the same topics.
-
Systems analysis to improve opioid use disorder care after jail release (SAIA-MOUD)
A program to help people with opioid use disorder get better, faster, and safer care after they leave jail.
-
Precise epigenetic drugs for opioid addiction
A tiny, targeted drug approach is being developed to help people with opioid use disorder by rewriting the epigenetic signals in the brain to reduce cravings and relapse risk.
-
Increasing Access to Medications for Opioid Use Disorder for Unhoused Montanans
This project helps unhoused people in Montana get life-saving medicines for opioid use disorder through clinics connected to syringe service programs, a nurse-led MOUD model, and peer support.
-
Optimizing long-acting PrEP and opioid treatment for people in jails and prisons
This project tests a real-world approach to using long-acting PrEP and buprenorphine for HIV prevention and opioid treatment among incarcerated individuals and after release.
-
Scaling up medications for opioid use disorder in residential treatment programs
This grant studies how to help residential treatment programs provide medications for opioid use disorder to reduce overdoses after discharge, focusing on real-world settings and policies.
-
Increasing Capacity at a Native Community Clinic to Improve Opioid Care for urban AI/AN
This grant helps a Native American health clinic build its research capacity to better serve urban American Indian and Alaska Native people dealing with opioid use disorder and related health issues.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.